期刊文献+

血清胱抑素C同型半胱氨酸与脂蛋白a联合诊断脑梗塞的临床价值 被引量:2

Clinical Value of Serum Cystatin C,Homocysteine and Lipoprotein a in Diagnosis of Cerebral Infraction
下载PDF
导出
摘要 目的研究血清胱抑素C同型半胱氨酸和脂蛋白a联合诊断脑梗塞的临床价值。方法方便选择该院在2016年8月—2017年8月收治的50例脑梗塞患者作为实验组,选择同时期在该院体检的正常人员作为对照组,对两组患者的临床危险因素和相应的实验室检查指标进行全面的观察,并且对其进行对比和统计学分析。结果对照组的血清胱抑素C、同型半胱氨酸和脂蛋白a的水平分别为(0.91±0.22)mg/L、(7.91±2.05)μmol/L、(177.50±91.28)mg/L,实验组的血清胱抑素C、同型半胱氨酸和脂蛋白a的水平分别为(1.64±0.81)mg/L、(13.25±4.10)μmol/L、(282.25±184.25)mg/L,明显实验组血清胱抑素C、同型半胱氨酸及脂蛋白a的水平比对照组高,数据差异有统计学意义(t=5.632、8.254、4.925,P<0.05)。结论血清胱抑素C、同型半胱氨酸及脂蛋白a的水平升高属于脑梗塞疾病发病的主要危险因素,将三者应用到脑梗塞患者病情评估和治疗过程中具有重要的现实意义,其值得临床推广使用。 Objective To research the clinical value of serum cystatin C, homocysteine and lipoprotein a in diagnosis of cerebral infraction. Methods 50 cases of cerebral infraction patients admitted and treated in our hospital from August 2016 to August 2017 were convenient selected as the experimental group, while the normal staff for physical examination at the same period were selected as the control group, and the clinical risk factors and corresponding laboratory examination indicators were comprehensively observed, and compared. Results The serum cystatin C, homocysteine and lipoprotein a in the control group were obviously higher than those in the control group [(0.91 ±0.22)mg/L,(7.91 ±2.05)μmol/L,(177.50 ±91.28)mg/L vs(1.64±0.81)mg/L,(13.25±4.10)μmol/L,(282.25±184.25)mg/L], and the differences were statistically significant,(t=t=5.632, 8.254,4.925,P〈0.05). Conclusion The serum cystatin C, homocysteine and lipoprotein a are the major risk factors,and the application of the three in the evaluation and treatment course of cerebral infraction is of important realistic significance, which is worth clinical promotion and application.
作者 孙前进 SUN Qian-jin(Department of Clinical Laboratory,Xuzhou Hospital of TCM,Xuzhou,Jiangsu Province,221000 China)
出处 《中外医疗》 2018年第11期41-43,共3页 China & Foreign Medical Treatment
关键词 血清胱抑素C 半胱氨酸 脂蛋白A 脑梗塞 Serum eystatin C Homoeysteine Lipoprotein a Cerebral infraction
  • 相关文献

二级参考文献57

  • 1李治国,周霞,张浩,齐丽荣.胱抑素C、同型半胱氨酸及N末端B型利钠肽原检测在老年慢性心力衰竭患者中的应用[J].中国老年学杂志,2014,34(11):3137-3138. 被引量:19
  • 2各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33037
  • 3Boysen G,Brander T, Christensen H, et al. Homocysteine andrisk of recurrent stroke[J]. Stroke.2003 ,34(5) : 1 258-1 261.
  • 4SUN Y, CHIEN KL, HSU HC, et al. Use of serum homocysteine to predict stroke, corollary heart disease and death in ethnic Chinese: 12-year prospective cohort study[J]. Circ J, 2009, 73(8): 1423-1430.
  • 5OH MY, LEE H, KIM JS, et al renal function, reflects severity Ncurol, 2014, 12(14): 127. Cystatin C, a novel indicator of of cerebral microbleeds[J]. BMC.
  • 6ANSARI R, MAHTA A, MALLACK E, et al. Hyperhomocys- teinemia and neurologic disorders: a review[J]. J Clin Neurol,2014, 10(4): 281-288.
  • 7MUSSAP M, PLEBANI M. Biochemistry and clinical role of hu- man Cystatin C[J]. Crit Rev Clin Lab Sci, 2004, 41(5/6): 467-550.
  • 8BENGTSSON E, TO F, GUBB A, et al. Absence of the protease inhibitor cystatin C in inflammatory cells results in largerplaque area in plaque Regression of apo E-deficientemice[J]. Athreroscle- rosis, 2005, 180(1): 45-53.
  • 9RITZ E. Heart and kidney:fatal twins[J]. Am J Med, 2006, 119 (1): 31-39.
  • 10GAUTHIER S, KAUR G, MI W, et al. Protective mechanisms by cystatin C in neurodegenerative diseases [J]. Front Biosci (Schol Ed), 2011, 3: 541-554.

共引文献109

同被引文献6

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部